ArticleBMJ global health2024
May Measurement Month 2022: results from the global blood pressure screening campaign.
Article in BMJ global health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
40 citing papers in PubMed.
- Article
- Striking Ethnic Disparities in Cardiometabolic Health in Albania: Divergent Burdens Across Minority Groups.Journal of racial and ethnic health disparities · 2026Article
- Joint association of body roundness index and HOMA-IR with risk of MASLD in Korean populations.BMC endocrine disorders · 2026Article
- Comparison between automated electronic blood pressure monitor and electrocardiography in atrial fibrillation screen.Journal of geriatric cardiology : JGC · 2026Article
- The Impact on Audience Engagement of Coordinating a Public Health Campaign on Antimicrobial Resistance Through a Network of Health Content Creators: Longitudinal Observational Study.JMIR public health and surveillance · 2026Observational
- Unmasking the contemporary burden of hypertension in Lagos, Nigeria: insights from an opportunistic screening.BMC public health · 2026Article
- Diabetes risk assessment in Polish community pharmacies. Results from a pilot national screening campaign.Archives of medical science : AMS · 2026Article
- Contribution of Final-Year Medical Students to Hypertension Diagnosis in Primary Care Units.Clinics and practice · 2025Article
- May Measurement Month 2022: an analysis of blood pressure screening results from China.European heart journal supplements : journal of the European Society of Cardiology · 2025Article
- May Measurement Month 2022: an analysis of blood pressure screening results from Brazil.European heart journal supplements : journal of the European Society of Cardiology · 2025Article
- May Measurement Month 2022: an analysis of blood pressure screening results from Mauritius.European heart journal supplements : journal of the European Society of Cardiology · 2025Article
- May Measurement Month 2022: an analysis of blood pressure screening results from Georgia.European heart journal supplements : journal of the European Society of Cardiology · 2025Article
- May Measurement Month 2022: an analysis of blood pressure screening results from Libya.European heart journal supplements : journal of the European Society of Cardiology · 2025Article
- May Measurement Month 2022: an analysis of blood pressure screening results from Mozambique.European heart journal supplements : journal of the European Society of Cardiology · 2025Article
- May Measurement Month 2022: an analysis of blood pressure screening results from Armenia.European heart journal supplements : journal of the European Society of Cardiology · 2025Article
- May Measurement Month 2022: an analysis of blood pressure screening results from Vietnam.European heart journal supplements : journal of the European Society of Cardiology · 2025Article
- May Measurement Month 2022: an analysis of blood pressure screening results from Ghana.European heart journal supplements : journal of the European Society of Cardiology · 2025Article
- May Measurement Month 2022: an analysis of blood pressure screening results from the UK and Republic of Ireland.European heart journal supplements : journal of the European Society of Cardiology · 2025Article
- May Measurement Month 2022: an analysis of blood pressure screening results from Nigeria.European heart journal supplements : journal of the European Society of Cardiology · 2025Article
- May Measurement Month 2022: an analysis of blood pressure screening results from the Republic of the Congo.European heart journal supplements : journal of the European Society of Cardiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
introductionElevated blood pressure (BP) is the major contributor to mortality and disease burden worldwide. May Measurement Month (MMM) is a global BP screening campaign, which aims to raise awareness of BP measurement and provide evidence to inform and influence related health policy.
methodsThis cross-sectional survey included individuals aged≥18 years recruited through opportunistic sampling at sites in 60 countries during MMM 2022. Each participant had three sitting BP measurements and a questionnaire was completed including demographics, comorbidities and lifestyle factors. Hypertension was defined as a systolic BP≥140 mm Hg and/or a diastolic BP≥90 mm Hg (average of the second and third readings) or taking antihypertensive medication. Multiple imputation was used to estimate BP readings where any participant's BP readings were missing. Linear mixed effects models were used to identify associations between participant characteristics and systolic or diastolic BP.
resultsOf the 715 518 participants surveyed (excluding 50 200 self-measured home BP screenees recruited via the ZOE Health Study app), 257 421 (36.0%) were identified as hypertensive, of whom 57.6% were aware and 49.3% were on antihypertensive medication. Of all participants with hypertension, 26.1% were controlled to <140/90 mm Hg and 12.0% to <130/80 mm Hg. Of those taking antihypertensive medication, 52.7% were taking only one drug class, 52.9% were controlled to <140/90 mm Hg and 24.4% to 130/80 mm Hg. In total, 190 314 (26.6% of total surveyed, 73.9% of hypertensives) participants screened were found to have untreated or inadequately treated hypertension. Only 27.6% of treated hypertensive participants were taking a statin. Substantial coexistence of diabetes, overweight and hypertension was apparent among participants.
conclusionsMMM confirms a high global burden of hypertension with low rates of awareness, treatment and control. In the absence of systematic BP screening in many countries, the results from MMM underscore the continued need for BP screening to detect and thereby control raised BP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.